Login

MorningTradeLive features MeridianLink CEO Nicolaas Vlok discussing the company's first earnings report as a public company with Oliver Renick. 00:10:00

Share On Facebook Share On Twitter

Nicolaas Vlok | CEO - MeridianLink, Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE Executive Chair, biOasis Technologies Inc
00:10:00
HSBC Initiates Buy Ratings on Marriott and Booking Holdings Amid Consumer Spending Concerns
00:00:00
Mike McCormick, CEO, Osprey Medical Inc
00:00:00
Dr Nicolas Poirier , CEO, Ose Immunotherapeutics
00:10:00
Brandt Tractor Showcases Cutting-Edge GPS and Data Management Technologies at Western Canadian Crop Production Show
00:10:00
Leaders of Listed Companies Gather in Lyon for Strategy Talks Amid Complex Economic Environment | Xavier Barbaro, CEO, Neoen SA.
00:10:00
Corporate Venture Capital and its Benefits|Bart Emery,Corporate Venture Capital Manager,Inflect Health
00:10:00
Lawrence Stroll Discusses Aston Martin's Future Amid Geely Investment and Global Relations | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.
00:10:00
Creating a world where companies and services work together|CEO, Biprogy Inc
00:10:00
Sierra Metals CEO Discusses Growth and Future Prospects at the 1-2-1 Mining Investment Conference
00:10:00
Faraday Copper Unveils High-Grade Banjo Breccia Discovery at Copper Creek
00:10:00
TECOM Group CEO Abdulla Belhoul Reflects on Strong First-Year Performance as a Publicly Listed Company | Abdulla Belhoul, CEO ,TECOM Group

© 2017 - Neuhu+